Cargando…

Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment

Fibroblast growth factor receptor 3 (FGFR3) alters frequently across various cancer types and is a common therapeutic target in bladder urothelial carcinoma (BLCA) with FGFR3 variants. Although emerging evidence supports the role of FGFR3 in individual cancer types, no pan-cancer analysis is availab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Juanni, Hu, Kuan, Huang, Jinzhou, Zhou, Lei, Yan, Yuanliang, Xu, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266346/ https://www.ncbi.nlm.nih.gov/pubmed/34160364 http://dx.doi.org/10.18632/aging.203175

Ejemplares similares

An integrative pan cancer analysis of RET aberrations and their potential clinical implications
por: Zhou, Lei, et al.
Publicado: (2022)

Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
por: Li, Juanni, et al.
Publicado: (2020)

A Pancancer Analysis of the Expression Landscape and Clinical Relevance of Fibroblast Growth Factor Receptor 2 in Human Cancers
por: Li, Juanni, et al.
Publicado: (2021)

Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
por: Zhou, Zhiyang, et al.
Publicado: (2021)

Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis
por: Yi, Qiaoli, et al.
Publicado: (2022)

Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis
por: Long, Guo, et al.
Publicado: (2023)

The novel roles of virus infection-associated gene CDKN1A in chemoresistance and immune infiltration of glioblastoma
por: Hu, Kuan, et al.
Publicado: (2021)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma
por: Hu, Kuan, et al.
Publicado: (2021)

BTB/POZ domain‐containing protein 7/hypoxia‐inducible factor 1 alpha signalling axis modulates hepatocellular carcinoma metastasis
por: Hu, Kuan, et al.
Publicado: (2021)

Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration
por: Hu, Kuan, et al.
Publicado: (2021)

A comprehensive pan-cancer study of fibroblast growth factor receptor aberrations in Chinese cancer patients
por: Sun, Yi, et al.
Publicado: (2020)

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
por: Cai, Yuan, et al.
Publicado: (2021)

Expression profile and prognostic values of Chromobox family members in human glioblastoma
por: Li, Juanni, et al.
Publicado: (2022)

Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis
por: Liu, Haijing, et al.
Publicado: (2020)

Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors
por: Liang, Qiuju, et al.
Publicado: (2022)

An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas
por: Yan, Yuanliang, et al.
Publicado: (2017)

Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma
por: Hu, Kuan, et al.
Publicado: (2022)

Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations
por: Murugesan, K., et al.
Publicado: (2022)

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma
por: Cai, Yuan, et al.
Publicado: (2021)

Downregulated Ferroptosis-Related Gene STEAP3 as a Novel Diagnostic and Prognostic Target for Hepatocellular Carcinoma and Its Roles in Immune Regulation
por: Yan, Yuanliang, et al.
Publicado: (2021)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
por: Kim, Young Saing, et al.
Publicado: (2018)

A DNA Aptamer That Inhibits the Aberrant Signaling of Fibroblast Growth Factor Receptor in Cancer Cells
por: Eguchi, Akihiro, et al.
Publicado: (2021)

The bioinformatics and experimental analysis of the novel roles of virus infection-associated gene CDC20 for prognosis and immune infiltration in hepatocellular carcinoma
por: Li, Juanni, et al.
Publicado: (2022)

Current insights into the functional roles of ferroptosis in musculoskeletal diseases and therapeutic implications
por: Zhang, Fan, et al.
Publicado: (2023)

Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
por: Lu, Can, et al.
Publicado: (2022)

A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values
por: Liu, Ying, et al.
Publicado: (2022)

Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics
por: Parish, A, et al.
Publicado: (2015)

The effects and the mechanisms of autophagy on the cancer-associated fibroblasts in cancer
por: Yan, Yuanliang, et al.
Publicado: (2019)

Downregulated PRNP Facilitates Cell Proliferation and Invasion and Has Effect on the Immune Regulation in Ovarian Cancer
por: Hu, Kuan, et al.
Publicado: (2022)

ALKBH family members as novel biomarkers and prognostic factors in human breast cancer
por: Chen, Hongxi, et al.
Publicado: (2022)

Current understanding of extrachromosomal circular DNA in cancer pathogenesis and therapeutic resistance
por: Yan, Yuanliang, et al.
Publicado: (2020)

Aberrant expression of KDM1A inhibits ferroptosis of lung cancer cells through up-regulating c-Myc
por: Lu, Can, et al.
Publicado: (2022)

New Insights Into the Role of Aberrant Hippocampal Neurogenesis in Epilepsy
por: Chen, Peng, et al.
Publicado: (2021)

Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential
por: Zhang, Wenqin, et al.
Publicado: (2022)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
por: Zhang, Zeyu, et al.
Publicado: (2022)

An integrated pan‐cancer analysis of TFAP4 aberrations and the potential clinical implications for cancer immunity
por: Liu, Jian‐Nan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qrjqklgr3m7r7ggl2bdp4jf6l3